Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Germ cell tumors, including teratomas and dysgerminomas, are rare ovarian tumors. They can be either benign or malignant. Treatment depends on the tumor type and stage, and may include surgery and chemotherapy. In some cases, there are treatment options that can preserve fertility.
Women with benign (non-cancerous) germ cell tumors such as mature teratomas (dermoid cysts) are cured by removing either the part of the ovary that has the tumor (ovarian cystectomy) or the entire ovary.
Most types and stages of germ cell cancers of the ovary are treated the same way, with surgery and chemotherapy (chemo).
About 2-3% of all ovarian cancers are germ cell tumors. Because these tumors are so uncommon, it’s a good idea to consult with a gynecologic oncologist for treating malignant germ cell tumors.
In general, all women with malignant germ cell tumors will have the same type of staging surgery done for epithelial ovarian cancer.
For women who still want to be able to have children:
If preserving fertility is not a concern, complete staging including removing both ovaries, both fallopian tubes, and the uterus is generally recommended.
If cancer has spread beyond the ovaries, debulking surgery may be done as a part of the initial surgery. This removes as much cancer as possible without damaging or removing essential organs.
Most women with germ cell cancer will need to be treated with combination chemo for at least 3 cycles. The combination used most often is PEB (or BEP), and includes the chemo drugs cisplatin, etoposide, and bleomycin.
Dysgerminomas are usually very sensitive to chemotherapy, and can sometimes be treated with the less toxic combination of carboplatin and etoposide.
Other drug combinations may be used to treat cancer that has recurred (come back) or hasn't responded to treatment.
Germ cell cancers can raise blood levels of the tumor markers human chorionic gonadotropin (HCG), alpha-fetoprotein (AFP), and/or lactate dehydrogenase (LDH). If the blood levels of these are high before treatment starts, they are rechecked during chemo (usually before each cycle). If the chemo is working, the levels will go down. If the levels stay up, it might be a sign that a different treatment is needed.
If dysgerminoma is limited to one ovary, surgery to remove that ovary and the fallopian tube on the same side might be the only treatment needed, without chemo after surgery.
This approach requires close follow-up so that if the cancer comes back it can be found early and treated. Most women in this stage are cured with surgery and never need chemo.
A grade 1 immature teratoma is made up mostly of non-cancerous tissue, with only a few cancerous areas visible. These tumors rarely come back after being removed.
If careful staging has determined that a grade 1 immature teratoma is limited to one or both ovaries, surgery to remove the affected ovary or ovaries and fallopian tube(s) might be the only treatment needed.
Sometimes increased blood levels of the tumor markers HCG and AFP will be the only sign that a germ cell cancer is still there (or has come back). Other times a definite tumor might be seen and removed by surgery.
Treatment for recurrent or persistent germ cell tumors might include surgery, chemo or, rarely, radiation therapy.
If chemo is used, a combination of drugs is most common:
Clinical trials may offer access to newer treatment options for these cancers. Ask your cancer care team about clinical trials you might be eligible for.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Cannistra SA, Gershenson DM, Recht A. Ch 76 - Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2015.
Morgan M, Boyd J, Drapkin R, Seiden MV. Ch 89 – Cancers Arising in the Ovary. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, Kastan MB, McKenna WG, eds. Clinical Oncology. 5th ed. Philadelphia, PA: Elsevier; 2014: 1592.
National Comprehensive Cancer Network (NCCN)--Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer. V2.2025. Accessed May 20, 2025, from https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf
Last Revised: August 8, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.